Filing search / Cartesian Therapeutics, Inc. / "Materials" / Page 3

DEFA14A

jl8 2enl4

14 Feb 24

Additional proxy soliciting materials

5:27pm

8-K

EX-99.1

gsi6o4mgbb

8 Jan 24

Regulation FD Disclosure

8:45am

8-K

nh6na ftaa

8 Jan 24

Regulation FD Disclosure

8:45am

D/A

l8ap f9c78qh1z

4 Dec 23

$60.25 mm in other securities, sold $60.25 mm, 2 investors

4:39pm

D

ckas1kfc

1 Dec 23

$60.25 mm in other securities, sold $60.25 mm, 2 investors

4:43pm

DEFA14A

erg6rzy

13 Nov 23

Additional proxy soliciting materials

9:06am

8-K

EX-10.2

43jvz1ai sa

13 Nov 23

Entry into a Material Definitive Agreement

9:02am

8-K

7jfjvon 0uwkk

13 Nov 23

Entry into a Material Definitive Agreement

9:02am

8-K

EX-2.1

p0ku3nr5i70tg0

13 Nov 23

Entry into a Material Definitive Agreement

9:02am

8-K

EX-10.1

ftf2t

13 Nov 23

Entry into a Material Definitive Agreement

9:02am

8-K

EX-99.1

bqeyjyklg ushwtdfmxj

13 Nov 23

Entry into a Material Definitive Agreement

9:02am

8-K

EX-99.2

6mvar

13 Nov 23

Entry into a Material Definitive Agreement

9:02am

DEFA14A

bx1t84dc5m9147

13 Jun 23

Additional proxy soliciting materials

7:54am

DEFA14A

5n2tta

28 Apr 23

Additional proxy soliciting materials

4:20pm

8-K

11rht

14 Dec 22

Selecta Biosciences Announces Next Generation IgA Protease Clinical Candidate

8:05am